In the fight against COVID-19, two FDA-approved mRNA vaccines were developed by Pfizer/BioNTech (BNT162b2) and Moderna (mRNA-1273), which produce the SARS-CoV-2 spike protein to activate potent B and ...

Newly developed vaccine could protect against emerging SARS-CoV-2 variants and related coronaviruses that may jump from ...

Patients who received the original monovalent mRNA COVID-19 vaccine were less likely than unvaccinated patients to be hospitalized for COVID-19-associated VTE.

MIT and Caltech scientists designed a new vaccine targeting stable virus regions to protect against various coronavirus strains.

January 2025 marks five years since the beginning of the COVID-19 pandemic that resulted in 1,216,305 American deaths and ...

A new experimental vaccine developed by researchers could offer protection against emerging variants of SARS-CoV-2, as well ...

The next phase of pre-exposure prophylaxis against SARS-CoV-2 currently rests on the shoulders of a single monoclonal ...

Moderna awarded tender for the supply of Its mRNA Covid-19 vaccine in European Union: Cambridge, Massachusetts Monday, January 27, 2025, 12:00 Hrs [IST] Moderna, Inc. announced th ...

“Taken together, these results indicate that, once PNP or NNP patients develop neuro-PASC, whether they contracted SARS-CoV-2 infection prior to, or after SARS-CoV-2 vaccination makes little ...

The vast majority of people in a study with long COVID had experienced multiple SARS-CoV-2 infections over the course of a ...

Moderna wins EU tender to supply COVID-19 vaccines for up to four years, offering diverse formats like prefilled syringes to ...

This article explores how broadly neutralizing antibodies are being researched, not only for their potential in the ...